Published: 2022This resource list from our talk on Managing Your Medicines has links tips and links to help you understand and manage your medicines.
Published: 2014 LocalHCCA strongly supports the position of ADDACT in the need for review of these guidelines and believes these changes ensures clarity in current protocols and practice, and increases people’s choice, opportunity and access to treatments and medicines that offer effective management of ADHD and its associated effects.
Published: 2014 NationalHCCA supports the addition of Sofosbuvir and Simeprevir to the Australian Government’s Pharmaceutical Benefits Scheme (PBS). HCCA strongly advocates for the introduction of these treatments in Australia to ensure choice, opportunity and access to these medicines which present significant advantages over currently available treatment options.
Published: 2015 LocalWe are broadly supportive of the proposed items for discussion, however we feel the discussion paper is quite vague and it is difficult to get a sense of what the new draft standards will look like and how closely they will resemble the draft Controlled Medicine Prescribing Standards that were…
Published: 2018 NationalHCCA recognises that there will always be some misuse of such medications, and that the misuse of opioids is rising. However, many people in our communities use opioid medications to good effect, for relief from acute or chronic pain. HCCA seeks to ensure that those who need pain relief have…
Nursing & Midwifery Board of Australia: Endorsement of Scheduled Medicines for Registered Nurses Prescribing in Partnership
Published: 2018HCCA recognises that an expanded role for Registered Nurses (RNs) and Registered Midwives (RMs) in prescribing has the potential to deliver benefits to health care consumers. We fully support the Consultation Paper’s observation that many people currently experience unacceptable barriers to health care, including barriers to timely access to medicines.
Published: 2019 NationalConsumers will benefit from increased transparency of information on non-active ingredients currently included in therapeutic goods marketed in Australia. Access to information, such as ingredient information about medicines and other therapeutic goods, is part of the Australian Charter of Healthcare Rights (2nd Edition).